in this issue
World News and Views :: Top of the News
CPhI: Dr. Reddy’s builds large-scale API facility in India
11:13 AM MDT | October 16, 2012 | Deepti Ramesh in Madrid
Dr. Reddy’s Laboratories (Hyderabad, India), the second largest API company in the world in terms of sales, after Teva, says that it will open a new large-scale active pharmaceutical ingredient (API) manufacturing facility at Visakhapatnam, India later this year. The current global API manufacturing operations of Dr. Reddy’s include six plants in India; one plant at Mirfield, UK; and a plant at Cuernavaca, Mexico. All the facilities are approved by the US FDA. “As we grow we need production capacity to support this growth. Later this year, we...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee